Mantle Cell Lymphoma | Clinical

Increased Molecular Understanding Informs Mantle Cell Treatment Choices

October 02, 2022

Traditionally, MCL was dichotomized based on the age of the patient and their ability to tolerate intensive therapy, [but] now we have to take into consideration biological differences across patients that go well beyond age, says Andre H. Goy, MD.